Cargando…

Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic

BACKGROUND: There are many safety concerns regarding the use of antithymocyte globulin (ATG) in kidney transplant recipients (KTRs) during the ongoing COVID-19 pandemic. Hereby, we present our recent experience with ATG administration both as induction therapy and as an anti-rejection treatment. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolonko, Aureliusz, Więcek, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556699/ https://www.ncbi.nlm.nih.gov/pubmed/34697282 http://dx.doi.org/10.12659/AOT.933001

Ejemplares similares

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
por: Krzyżowska, Kinga, et al.
Publicado: (2018)

A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
por: Schweiger, Martin, et al.
Publicado: (2018)

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
por: Rafat, Shamim, et al.
Publicado: (2017)

Potential Utility of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Neutrophil, Lymphocyte, and Platelet Ratios in Differential Diagnosis of Kidney Transplant Acute Rejection: A Retrospective, Propensity Score Matched Analysis
por: Kolonko, Aureliusz, et al.
Publicado: (2022)

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
por: Mai, Hoa Le, et al.
Publicado: (2018)

The Association of Long-Functioning Hemodialysis Vascular Access with Prevalence of Left Ventricular Hypertrophy in Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2014)

Association between Kidney Donor Risk Index, kidney graft function and histological changes in early post-transplant graft biopsy
por: Słabiak-Błaż, Natalia, et al.
Publicado: (2023)

Number of Regularly Prescribed Drugs and Intrapatient Tacrolimus Trough Levels Variability in Stable Kidney Transplant Recipients
por: Giza, Piotr, et al.
Publicado: (2020)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

The effect of Maintenance Treatment with Twice-daily or Prolonged Once-daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2020)

Influence of Chronic Periodontitis on the Long-Term Mortality and Cardiovascular Events in Kidney Transplant Recipients
por: Wynimko, Marta, et al.
Publicado: (2020)

The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation
por: Kolonko, Aureliusz, et al.
Publicado: (2021)

Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection
por: Kitto, Brent, et al.
Publicado: (2021)

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018)

Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019)

Antithymocyte globulin/methylprednisolone: COVID-19 infection: case report
Publicado: (2021)

Clinical Outcomes of Transplanted Kidneys from Deceased Donors Using Different Generic Preservation Solutions
por: Kolonko, Aureliusz, et al.
Publicado: (2022)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants
por: Musialik, Joanna, et al.
Publicado: (2022)

Reactivation of Hemophagocytic Lymphohistiocytosis Triggered by Antithymocyte Globulin
por: Matsuda, Kensuke, et al.
Publicado: (2017)

Comparing the effect of induction therapy with or without antithymocyte globulin on renal allograft outcomes in live-donor kidney transplant recipients
por: Marghoob, Bahareh, et al.
Publicado: (2019)

Intestinal Permeability in Patients Early after Kidney Transplantation Treated with Two Different Formulations of Once-Daily Tacrolimus
por: Kolonko, Aureliusz, et al.
Publicado: (2023)

Type 1 Diabetic Patients After Simultaneous Pancreas and Kidney Transplantation Have Less Intense Periodontal Inflammation Compared to Kidney Recipients Treated with Insulin
por: Musiał, Mikołaj, et al.
Publicado: (2021)

The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation
por: Linhares, Kamilla, et al.
Publicado: (2021)

The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2018)

Rabbit Antithymocyte Globulin Causes Blastomyces and Histoplasma Antigenemia
por: Kaur, Amrit, et al.
Publicado: (2019)

The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series
por: Kolonko, Aureliusz, et al.
Publicado: (2020)

Guillain–Barre syndrome after antithymocyte globulin administration in a kidney transplant recipient: A case report and literature review
por: Tavakoli, Farnaz, et al.
Publicado: (2023)

Arterial stiffness but not endothelial dysfunction is associated with multidrug antihypertensive therapy and nondipper blood pressure pattern in kidney transplant recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2018)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
por: Pourmand, G. R., et al.
Publicado: (2012)

Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study
por: Harrison, Jennifer J, et al.
Publicado: (2014)

Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?
por: Guirado, Lluís
Publicado: (2018)

Successful desensitization of a patient with aplastic anemia to antithymocyte globulin
por: Wolanin, Stephanie A., et al.
Publicado: (2015)

Severe Acute Interstitial Nephritis: Response to Therapy With Antithymocyte Globulin
por: Shao, Tiffany, et al.
Publicado: (2016)

Antithymocyte-globulin/mycophenolate-mophetil: Lymphopenia: 3 case reports
Publicado: (2021)

Antithymocyte-globulin/ciclosporin/eltrombopag: Lack of efficacy: case report
Publicado: (2022)

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report
por: Park, Yohan, et al.
Publicado: (2020)

Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation
por: Yuan, Jiaojiao, et al.
Publicado: (2017)

The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period
por: Duhart, Benjamin T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_do3tkqvdg4bpsa4cj2uejnag38